This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Articles

Ziprasidone and Cognition: The Evolving Story

Article Abstract

Cognitive impairment, a central characteristic of schizophrenia, can profoundly limit patients’ ability to acquire or maintain skills needed for adequate functioning. Thus, research on the efficacy ofantipsychotic medications is increasingly focusing on the possible benefits of these agents on cognitivefunction. Although data are limited, it appears that atypical antipsychotics consistently improvecognitive function to a greater extent than do older, conventional agents. This review focuses on theatypical agent ziprasidone and its effects on cognitive function. The most recent data on the cognitiveeffects of ziprasidone come from a comparative trial with olanzapine (40-80 mg b.i.d. and 5-15 mgq.d., respectively) and from 3 studies in which patients were switched to ziprasidone (40-160 mg/day)because of suboptimal efficacy or tolerability with other antipsychotics. In general, ziprasidonetreatedpatients demonstrated significant improvements in multiple cognitive domains—such as episodicmemory, attention/vigilance, executive function, and visuomotor speed—that are generally associatedwith improved functional outcome. In the switching studies, path analysis indicated thatimprovement on the Positive and Negative Syndrome Scale (PANSS) cognitive subscale directly affectedchanges on the PANSS anxiety-depression cluster and a PANSS “prosocial” subscale composedof items related to social engagement. Improvement in cognitive function observed with ziprasidonemay have implications for long-term patient outcomes.


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 64

Quick Links: Neurologic and Neurocognitive , Neurology